tetano
Editor, Senior Moderator
Am J Transl Res
. 2024 Apr 15;16(4):1468-1476.
doi: 10.62347/KYKR6707. eCollection 2024. Efficacy of cardiopulmonary rehabilitation nursing in enhancing pulmonary function, sleep quality, and living ability in COVID-19 patients
Hua Chen[SUP] 1 [/SUP], Zhuling Dai[SUP] 1 [/SUP], Guohua Huang[SUP] 1 [/SUP], Shuqin Yang[SUP] 2 [/SUP], Liang Qian[SUP] 2 [/SUP], Qiao Luo[SUP] 2 [/SUP], Jianjun Li[SUP] 2 [/SUP], Qin Su[SUP] 2 [/SUP], Xiaojuan Shu[SUP] 2 [/SUP], Xiuyan Fu[SUP] 3 [/SUP], Yinyan Wang[SUP] 3 [/SUP], Yuqing Xia[SUP] 1 [/SUP], Li Wang[SUP] 1 [/SUP], Taibing Deng[SUP] 1 [/SUP], Junjie Wen[SUP] 1 [/SUP]
Affiliations
Objective: The purpose of this study was to elucidate the impact of cardiopulmonary rehabilitation nursing on the pulmonary function, sleep quality, and living ability of patients afflicted with Coronavirus Disease 2019 (COVID-19).
Methods: A total of 98 patients with COVID-19 treated at The People's Hospital of Guang'an between September 2021 and January 2023 were retrospectively collected as the research subjects. Among them, 48 patients who received standard nursing care from September 2021 to September 2022 were set as the control group, and 50 patients who underwent cardiopulmonary rehabilitation nursing from October 2022 to January 2023 were set as the research group. The pulmonary function indicators [including Forced Expiratory Volume in 1 second (FEV1) and Left Ventricular Ejection Fraction (LVEF)], sleep quality [evaluated using the Pittsburgh Sleep Quality Index (PSQI)], and living ability [assessed by the 36-Item Short Form Survey (SF-36) scale] pre- and post-intervention were compared between the two groups.
Results: Pre-intervention, FEV1, LVEF, PSQI scores, inflammatory factor levels [C-reactive protein (CRP), procalcitonin (PCT)], and SF-36 scores showed no significant differences between the two groups (P>0.05). Post-intervention, the research group exhibited notably enhanced FEV1 and LVEF, lower PSQI scores, lower CRP and PCT, and higher SF-36 scores compared with the control group, with statistical significance (P<0.05). Multifactorial logistic regression analysis showed that non-receipt of cardiopulmonary rehabilitation, age ≥60 years, concurrent respiratory failure, coexistent heart failure, and acid-base imbalance were independent risk factors of adverse outcomes in COVID-19 patients (P<0.05).
Conclusion: Application of cardiopulmonary rehabilitation nursing in COVID-19 patients can significantly improve pulmonary function, sleep quality, and overall quality of life, and relieve the inflammatory state of the patients, thereby enhancing prognosis. This approach has certain value of popularization and application.
Keywords: COVID-19; Cardiopulmonary rehabilitation nursing; pulmonary function; quality of life; sleep quality.
. 2024 Apr 15;16(4):1468-1476.
doi: 10.62347/KYKR6707. eCollection 2024. Efficacy of cardiopulmonary rehabilitation nursing in enhancing pulmonary function, sleep quality, and living ability in COVID-19 patients
Hua Chen[SUP] 1 [/SUP], Zhuling Dai[SUP] 1 [/SUP], Guohua Huang[SUP] 1 [/SUP], Shuqin Yang[SUP] 2 [/SUP], Liang Qian[SUP] 2 [/SUP], Qiao Luo[SUP] 2 [/SUP], Jianjun Li[SUP] 2 [/SUP], Qin Su[SUP] 2 [/SUP], Xiaojuan Shu[SUP] 2 [/SUP], Xiuyan Fu[SUP] 3 [/SUP], Yinyan Wang[SUP] 3 [/SUP], Yuqing Xia[SUP] 1 [/SUP], Li Wang[SUP] 1 [/SUP], Taibing Deng[SUP] 1 [/SUP], Junjie Wen[SUP] 1 [/SUP]
Affiliations
- PMID: 38715809
- PMCID: PMC11070360
- DOI: 10.62347/KYKR6707
Objective: The purpose of this study was to elucidate the impact of cardiopulmonary rehabilitation nursing on the pulmonary function, sleep quality, and living ability of patients afflicted with Coronavirus Disease 2019 (COVID-19).
Methods: A total of 98 patients with COVID-19 treated at The People's Hospital of Guang'an between September 2021 and January 2023 were retrospectively collected as the research subjects. Among them, 48 patients who received standard nursing care from September 2021 to September 2022 were set as the control group, and 50 patients who underwent cardiopulmonary rehabilitation nursing from October 2022 to January 2023 were set as the research group. The pulmonary function indicators [including Forced Expiratory Volume in 1 second (FEV1) and Left Ventricular Ejection Fraction (LVEF)], sleep quality [evaluated using the Pittsburgh Sleep Quality Index (PSQI)], and living ability [assessed by the 36-Item Short Form Survey (SF-36) scale] pre- and post-intervention were compared between the two groups.
Results: Pre-intervention, FEV1, LVEF, PSQI scores, inflammatory factor levels [C-reactive protein (CRP), procalcitonin (PCT)], and SF-36 scores showed no significant differences between the two groups (P>0.05). Post-intervention, the research group exhibited notably enhanced FEV1 and LVEF, lower PSQI scores, lower CRP and PCT, and higher SF-36 scores compared with the control group, with statistical significance (P<0.05). Multifactorial logistic regression analysis showed that non-receipt of cardiopulmonary rehabilitation, age ≥60 years, concurrent respiratory failure, coexistent heart failure, and acid-base imbalance were independent risk factors of adverse outcomes in COVID-19 patients (P<0.05).
Conclusion: Application of cardiopulmonary rehabilitation nursing in COVID-19 patients can significantly improve pulmonary function, sleep quality, and overall quality of life, and relieve the inflammatory state of the patients, thereby enhancing prognosis. This approach has certain value of popularization and application.
Keywords: COVID-19; Cardiopulmonary rehabilitation nursing; pulmonary function; quality of life; sleep quality.